Ohio Public Employees Retirement System (OPERS)’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162K Buy
15,193
+8,100
+114% +$82K ﹤0.01% 1710
2025
Q4
$66.5K Buy
+7,093
New +$55.5K ﹤0.01% 1881
2024
Q4
Sell
-8,272
Closed -$44.5K 2372
2024
Q3
$44.5K Sell
8,272
-14,121
-63% -$66.4K ﹤0.01% 1804
2024
Q2
$75K Sell
22,393
-1,355
-6% -$5.28K ﹤0.01% 1464
2024
Q1
$95.7K Sell
23,748
-2,590
-10% -$6.92K ﹤0.01% 1423
2023
Q4
$69.8K Buy
+26,338
New +$60.3K ﹤0.01% 1482

Other funds holding DSGN

Ohio Public Employees Retirement System (OPERS)'s DSGN Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Design Therapeutics (DSGN) stake by 114% in Q1 2026, buying an estimated $82K and bringing the position to 15,193 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

Ohio Public Employees Retirement System (OPERS) first reported a position in DSGN in Q4 2023 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 15,193 shares of Design Therapeutics worth $162K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 8,100 Design Therapeutics shares in Q1 2026, an estimated $82K.
  • Design Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1710 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Design Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.